Literature DB >> 10411589

Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters.

F A Paczkowski1, L J Bryan-Lluka, P Pörzgen, M Brüss, H Bönisch.   

Abstract

The aims of this study were to characterize the recently cloned rat norepinephrine transporter (NET) in more detail and in particular to study possible species differences in its pharmacological properties compared with the human and bovine NETs. The study was carried out by measuring the uptake of [(3)H]norepinephrine in COS-7 cells expressing the NET after transient transfection with rat, human, or bovine NET cDNA. There were small but significant differences between the rat NET and the human or bovine NETs with respect to the affinities of sodium ions (greater for rat than for bovine) of the substrates norepinephrine, epinephrine, and 1-methyl-4-phenylpyridinium (greater for human than for rat), and of the inhibitor cocaine (greater for human and bovine than for rat), whereas the affinities of dopamine and of most inhibitors, including tricyclic antidepressants, showed no species differences. The fact that the affinities for some substrates, cocaine and sodium ions exhibited small but significant interspecies differences among the rat, human, and bovine NETs suggests that ligand recognition, the translocation process, and sodium ion dependence are influenced differentially by just a few amino acid exchanges in the primary sequences of the transporters. On the other hand, the lack of any major differences in the pharmacological properties of the rat, human, and bovine NETs in this study suggests that data obtained in previous studies on rat tissues and bovine cells can be extrapolated, in all except the most quantitative analyses, to the properties of the human NET.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411589

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Chamber-specific alterations of noradrenaline uptake (uptake(1)) in right ventricles of monocrotaline-treated rats.

Authors:  K Leineweber; T Seyfarth; O E Brodde
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.

Authors:  Nadia Ayala-Lopez; William F Jackson; Robert Burnett; James N Wilson; Janice M Thompson; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-02       Impact factor: 4.733

3.  Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.

Authors:  Jesse D Hoffmeister; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Behav Brain Res       Date:  2021-10-28       Impact factor: 3.332

4.  Helix XI contributes to the entrance of the serotonin transporter permeation pathway.

Authors:  Melissa I Torres-Altoro; Kellie J White; Gustavo J Rodríguez; David E Nichols; Eric L Barker
Journal:  Protein Sci       Date:  2008-07-15       Impact factor: 6.725

5.  Molecular cloning and functional expression of the murine noradrenaline transporter.

Authors:  Andrea Muck; Ralf Gilsbach; Sandra Löbbe-Werner; Michael Brüss; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-19       Impact factor: 3.000

6.  Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).

Authors:  Lesley J Bryan-Lluka; Marisa H Papacostas; Filip A Paczkowski; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

7.  Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.

Authors:  Timothy Lynagh; Tina S Khamu; Lesley J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-01       Impact factor: 3.000

8.  Dynamic monitoring of single-terminal norepinephrine transporter rate in the rodent cardiovascular system: A novel fluorescence imaging method.

Authors:  Lily L Cao; Andrew P Holmes; Janice M Marshall; Larissa Fabritz; Keith L Brain
Journal:  Auton Neurosci       Date:  2019-12-26       Impact factor: 3.145

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.